Analyst Price Targets — LNTH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 27, 2026 5:04 pm | Richard Newitter | Truist Financial | $89.00 | $74.91 | StreetInsider | Lantheus Holdings (LNTH) PT Raised to $89 at Truist Securities |
| December 18, 2025 2:12 pm | — | Truist Financial | $82.00 | $65.35 | TheFly | Lantheus price target raised to $82 from $80 at Truist |
| December 17, 2025 11:58 am | — | Mizuho Securities | $72.00 | $65.17 | TheFly | Lantheus price target raised to $72 from $60 at Mizuho |
| December 11, 2025 9:32 pm | Richard Newitter | Truist Financial | $80.00 | $63.09 | TheFly | Lantheus upgraded to Buy at Truist on profit re-acceleration prospects |
| October 8, 2025 8:29 am | — | Goldman Sachs | $77.00 | $51.84 | TheFly | Lantheus downgraded to Neutral from Buy at Goldman Sachs |
| August 11, 2025 8:26 pm | Richard Newitter | Truist Financial | $63.00 | $56.07 | TheFly | Lantheus downgraded to Hold from Buy at Truist |
| December 18, 2024 9:26 am | Paul Choi | Goldman Sachs | $143.00 | $91.15 | TheFly | Lantheus initiated with a Buy at Goldman Sachs |
| September 3, 2024 5:28 am | Ed Ridley-Day | Redburn Partners | $175.00 | $106.47 | TheFly | Lantheus initiated with a Buy at Redburn Atlantic |
| August 1, 2024 7:13 am | David Turkaly | JMP Securities | $125.00 | $104.83 | TheFly | Lantheus price target lowered to $125 from $130 at JMP Securities |
| July 12, 2024 7:01 am | Anthony Petrone | Mizuho Securities | $165.00 | $123.62 | TheFly | Lantheus price target raised to $165 from $100 at Mizuho |
Latest News for LNTH
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Lantheus Holdings, Inc. (NasdaqGM: LNTH). In August of 2025, contrary to the Company's prior optimistic outlook for the growth potential of its flagship product, Pylarify, the Company…
Lantheus Holdings, Inc. (LNTH) Q4 2025 Earnings Call Transcript
BEDFORD, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today reported financial results for its fourth quarter and full year ended December 31, 2025.
BEDFORD, Mass. , Feb. 24, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better patient outcomes, today announced Mary Anne Heino, Executive Chairperson and Chief Executive Officer, will present at the following investor conferences.
/PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick and Foti, LLC ("KSF"), announces that
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for LNTH.
U.S. House Trading
No House trades found for LNTH.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.